Kevin Cross

Hematology Consultant at TG Therapeutics, Inc. - New York, NY, US

Kevin Cross's Colleagues at TG Therapeutics, Inc.
Sanatan Shreay

Executive Director and Head, Value Evidence

Contact Sanatan Shreay

Stehr Barbara

Regional Medical Liaison

Contact Stehr Barbara

Cole McIlwraith

Associate Director, Marketing

Contact Cole McIlwraith

Kristen Englund

Sr. Associate - R&D Quality

Contact Kristen Englund

Milan Patel

Regional Medical Liaison

Contact Milan Patel

Scott Donohue

Executive Director, Value and Policy

Contact Scott Donohue

Kacie Legendre

Regional Business Director

Contact Kacie Legendre

View All Kevin Cross's Colleagues
Kevin Cross's Contact Details
HQ
(212) 554-4484
Location
Mobile Metropolitan Area
Company
TG Therapeutics, Inc.
Kevin Cross's Company Details
TG Therapeutics, Inc. logo, TG Therapeutics, Inc. contact details

TG Therapeutics, Inc.

New York, NY, US • 380 Employees
BioTech/Drugs

TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS).

Pharmaceutical Research
Details about TG Therapeutics, Inc.
Frequently Asked Questions about Kevin Cross
Kevin Cross currently works for TG Therapeutics, Inc..
Kevin Cross's role at TG Therapeutics, Inc. is Hematology Consultant.
Kevin Cross's email address is ***@tgtxinc.com. To view Kevin Cross's full email address, please signup to ConnectPlex.
Kevin Cross works in the BioTech/Drugs industry.
Kevin Cross's colleagues at TG Therapeutics, Inc. are Sanatan Shreay, Stehr Barbara, Cole McIlwraith, Kristen Englund, Milan Patel, Scott Donohue, Kacie Legendre and others.
Kevin Cross's phone number is (212) 554-4484
See more information about Kevin Cross